MicroRNA-34a: the bad guy in age-related vascular diseases

被引:63
|
作者
Raucci, Angela [1 ]
Macri, Federica [1 ]
Castiglione, Stefania [1 ]
Badi, Ileana [1 ,3 ]
Vinci, Maria Cristina [2 ]
Zuccolo, Estella [1 ]
机构
[1] Ctr Cardiol Monzino IRCCS, Expt Cardiooncol & Cardiovasc Aging Unit, Via C Parea 4, I-20138 Milan, Italy
[2] Ctr Cardiol Monzino IRCCS, Unit Vasc Biol & Regenerat Med, Milan, Italy
[3] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England
关键词
Senescence; Inflammaging; microRNA; Vascular calcification; Atherosclerosis; Diabetes; SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY-DISEASE; MIR-34A EXPRESSION; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; PULMONARY-HYPERTENSION; ELEVATED MICRORNA-34A; EPIGENETIC REGULATION; DEPENDENT REGULATION; MONONUCLEAR-CELLS;
D O I
10.1007/s00018-021-03979-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The age-related vasculature alteration is the prominent risk factor for vascular diseases (VD), namely, atherosclerosis, abdominal aortic aneurysm, vascular calcification (VC) and pulmonary arterial hypertension (PAH). The chronic sterile low-grade inflammation state, alias inflammaging, characterizes elderly people and participates in VD development. MicroRNA34-a (miR-34a) is emerging as an important mediator of inflammaging and VD. miR-34a increases with aging in vessels and induces senescence and the acquisition of the senescence-associated secretory phenotype (SASP) in vascular smooth muscle (VSMCs) and endothelial (ECs) cells. Similarly, other VD risk factors, including dyslipidemia, hyperglycemia and hypertension, modify miR-34a expression to promote vascular senescence and inflammation. miR-34a upregulation causes endothelial dysfunction by affecting ECs nitric oxide bioavailability, adhesion molecules expression and inflammatory cells recruitment. miR-34a-induced senescence facilitates VSMCs osteoblastic switch and VC development in hyperphosphatemia conditions. Conversely, atherogenic and hypoxic stimuli downregulate miR-34a levels and promote VSMCs proliferation and migration during atherosclerosis and PAH. MiR34a genetic ablation or miR-34a inhibition by anti-miR-34a molecules in different experimental models of VD reduce vascular inflammation, senescence and apoptosis through sirtuin 1 Notch1, and B-cell lymphoma 2 modulation. Notably, pleiotropic drugs, like statins, liraglutide and metformin, affect miR-34a expression. Finally, human studies report that miR-34a levels associate to atherosclerosis and diabetes and correlate with inflammatory factors during aging. Herein, we comprehensively review the current knowledge about miR-34a-dependent molecular and cellular mechanisms activated by VD risk factors and highlight the diagnostic and therapeutic potential of modulating its expression in order to reduce inflammaging and VD burn and extend healthy lifespan.
引用
收藏
页码:7355 / 7378
页数:24
相关论文
共 50 条
  • [41] The role of sirtuins in aging and age-related diseases
    Watroba, Mateusz
    Szukiewicz, Dariusz
    ADVANCES IN MEDICAL SCIENCES, 2016, 61 (01): : 52 - 62
  • [42] Dietary approaches that delay age-related diseases
    Everitt, Arthur V.
    Hilmer, Sarah N.
    Brand-Miller, Jennie C.
    Jamieson, Hamish A.
    Truswell, A. Stewart
    Sharma, Anita P.
    Mason, Rebecca S.
    Morris, Brian J.
    Le Couteur, David G.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (01) : 11 - 31
  • [43] Targeting aging and age-related diseases with vaccines
    Wu, Ruochen
    Sun, Fei
    Zhang, Weiqi
    Ren, Jie
    Liu, Guang-Hui
    NATURE AGING, 2024, 4 (04): : 464 - 482
  • [44] Protein damage, ageing and age-related diseases
    Krisko, Anita
    Radman, Miroslav
    OPEN BIOLOGY, 2019, 9 (03)
  • [45] Health Benefits of Quercetin in Age-Related Diseases
    Deepika
    Maurya, Pawan Kumar
    MOLECULES, 2022, 27 (08):
  • [46] The role of mitochondrial dysfunction in age-related diseases
    Lane, Rebecca K.
    Hilsabeck, Tyler
    Rea, Shane L.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2015, 1847 (11): : 1387 - 1400
  • [47] THE ROLE OF IMMUNOSENESCENCE IN THE DEVELOPMENT OF AGE-RELATED DISEASES
    Fulop, Tamas
    Dupuis, Gilles
    Witkowski, Jacek M.
    Larbi, Anis
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2016, 68 (02): : 84 - 91
  • [48] The interplay between immunosenescence and age-related diseases
    Florencia Barbé-Tuana
    Giselle Funchal
    Carine Raquel Richter Schmitz
    Rafael Moura Maurmann
    Moisés E. Bauer
    Seminars in Immunopathology, 2020, 42 : 545 - 557
  • [49] Strategies for modeling aging and age-related diseases
    Jothi, D.
    Kulka, Linda Anna Michelle
    NPJ AGING, 2024, 10 (01):
  • [50] Senescent cells and the incidence of age-related diseases
    Katzir, Itay
    Adler, Miri
    Karin, Omer
    Mendelsohn-Cohen, Netta
    Mayo, Avi
    Alon, Uri
    AGING CELL, 2021, 20 (03)